Canada markets closed

Soleno Therapeutics Inc (6XC.BE)

Berlin - Berlin Delayed Price. Currency in EUR
Add to watchlist
38.54-0.54 (-1.38%)
At close: 08:08PM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
0
0
0
-
Operating Expenses
Research Development
34,475
25,189
15,265
21,453
23,191
-
Selling General and Administrative
19,099
13,481
9,844
10,806
8,758
-
Total Operating Expenses
53,574
38,670
25,109
32,259
31,949
-
Operating Income or Loss
-53,574
-38,670
-25,109
-32,259
-31,949
-
Total Other Income/Expenses Net
-2,998
-2,896
742
1,239
7,297
-
Income Before Tax
-52,030
-38,988
-24,067
-30,910
-24,639
-
Income from Continuing Operations
-52,030
-38,988
-24,067
-30,910
-24,639
-
Net Income
-52,030
-38,988
-24,067
-30,910
-24,639
-
Net Income available to common shareholders
-52,030
-38,988
-24,067
-30,910
-24,639
-
Basic EPS
-3.21
-
-2.87
-5.81
-5.85
-13.50
Diluted EPS
-3.21
-
-2.87
-5.81
-5.85
-13.50
Basic Average Shares
10,195
-
8,397
5,318
4,175
2,276
Diluted Average Shares
10,195
-
8,397
5,318
4,175
2,276